But, as a low level of plasmatic bile acids disrupts the activity of different receptors (G protein-coupled receptor 5, TGR5, and Farnesoid X receptor, FXR), alterations of bile acid metabolism and composition have been shown to promote the development of NAFLD [26, 27]. The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatotic liver disease.